CIK 0001553643
- Non-accelerated filer
- Smaller reporting company
RELMADA THERAPEUTICS, INC.
Sign in to watch- Ticker
- RLMD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 455401931
- Phone
- +1 646-876-3459
- Business address
- 2222 PONCE DE LEON BLVD. 3RD FLOOR, CORAL GABLES, FL, 33134
- Former names
- CAMP NINE, INC.
- Open-market buys, last 90 days
- $1,671,990
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$1,671,990. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-10-18 | Kelly Paul Edward Director | Purchase | +400 | $19.07 | $8K | 123,621 |
| 2019-10-18 | Kelly Paul Edward Director | Purchase | +100 | $19.08 | $2K | 123,721 |
| 2019-10-18 | Kelly Paul Edward Director | Purchase | +200 | $19.10 | $4K | 123,921 |
| 2019-10-18 | Kelly Paul Edward Director | Purchase | +100 | $19.15 | $2K | 124,021 |
| 2019-10-18 | Kelly Paul Edward Director | Purchase | +3,100 | $19.20 | $60K | 127,121 |
| 2019-07-29 | Vitolo Ottavio V. Chief Medical Officer | Grant or award · Options to purchase common stock | +150,000 | $2.20 | $330K | 150,000 |
| 2019-07-29 | Shenouda Maged Director | Grant or award · Options to purchase common stock | +500,000 | $2.20 | $1.1M | 500,000 |
| 2019-07-29 | Kelly Paul Edward Director | Grant or award · Options to purchase common stock | +600,000 | $2.20 | $1.3M | 600,000 |
| 2019-07-29 | CASAMENTO CHARLES J Director | Grant or award · Options to purchase common stock | +500,000 | $2.20 | $1.1M | 500,000 |
| 2019-07-29 | TRAVERSA SERGIO Chief Executive Officer | Grant or award · Options to purchase common stock | +1,700,000 | $2.20 | $3.7M | 1,700,000 |
| 2019-05-14 | Kelly Paul Edward Director | Purchase | +100,000 | $1.50 | $150K | 488,483 |
| 2019-05-14 | Kelly Paul Edward Director | Purchase · Warrant | +50,000 | $2.25 | $113K | 50,000 |
| 2018-12-20 | Vitolo Ottavio V. Chief Medical Officer | Grant or award · Options to purchase common stock | +400,000 | $1.15 | $460K | 400,000 |
| 2018-12-20 | TRAVERSA SERGIO Chief Executive Officer | Grant or award · Options to purchase common stock | +900,000 | $1.15 | $1.0M | 900,000 |
| 2018-12-20 | Shenouda Maged Director | Grant or award · Options to purchase common stock | +450,000 | $1.15 | $518K | 450,000 |
| 2018-12-20 | Kelly Paul Edward Director | Grant or award · Options to purchase common stock | +500,000 | $1.15 | $575K | 500,000 |
| 2018-12-20 | CASAMENTO CHARLES J Director | Grant or award · Options to purchase common stock | +450,000 | $1.15 | $518K | 450,000 |
| 2018-12-11 | Kelly Paul Edward Director | Purchase | +5,000 | $1.21 | $6K | 388,483 |
| 2018-10-18 | Kelly Paul Edward Director | Conversion | +223,483 | $0.72 | $161K | 383,483 |
| 2018-10-12 | Kelly Paul Edward Director | Purchase | +150,000 | $0.90 | $135K | 160,000 |
Page 16 of 19 · 370 trades